| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $185.3M | +20.1% |
| Cost of Revenue | $57.9M | +17.5% |
| R&D Expense | $141.8M | -0.4% |
| SG&A Expense | $88.5M | +18.8% |
| Operating Income | -$200.2M | +4.2% |
| Interest Expense | $4.2M | — |
| Pre-tax Income | -$200.4M | +3.3% |
| Net Income | -$200.2M | +3.4% |
| EPS (Basic) | -$1.40 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.0M | -35.3% |
| Accounts Receivable | $40.1M | +130.1% |
| Inventory | $14.5M | -25.0% |
| Current Assets | $562.1M | +39.6% |
| Total Assets | $856.6M | -7.2% |
| Current Liabilities | $109.8M | -3.5% |
| Total Liabilities | $392.5M | +23.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$183.9M | +4.6% |
| Capital Expenditures | $16.3M | -73.5% |
| Investing Cash Flow | $2.9M | -98.4% |
| Financing Cash Flow | $132.3M | +387.2% |
| Free Cash Flow | -$200.3M | +21.3% |
| +5.4% |
| EPS (Diluted) | -$1.40 | +5.4% |
| Stockholders' Equity |
| $464.2M |
| -23.2% |